Chronic inflammatory bowel diseases and reproduction - Current state of knowledge and treatment options;Chronisch entzündliche darmerkrankungen und reproduktion - Aktuelles zu datenlage und behandlungskonzepten

Geburtshilfe und Frauenheilkunde

Volumn 68, Issue 1, 2008, Pages 40-51

  Bohlmann, Michael K ^a,d   Luedders, D W ^a   Speer, R ^b   Hornemann, A ^a   Bohlmann, I ^c   Diedrich, K ^a  

^a Universitäts Frauenklinik Lübeck ^*

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Crohn's disease; Fertility; Inflammatory bowel disease; Pregnancy; Therapeutic options; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; GLUCOCORTICOID; HYDROCORTISONE; INFLIXIMAB; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS;

BREAST FEEDING; COLITIS; CROHN DISEASE; DISEASE ASSOCIATION; DYSPAREUNIA; ENTERITIS; FERTILITY; FETUS OUTCOME; HUMAN; INCIDENCE; MATERNAL WELFARE; PREECLAMPSIA; PREGNANCY; REPRODUCTION; REVIEW; SEXUAL FUNCTION; SURGICAL TECHNIQUE; TREATMENT PLANNING; ULCERATIVE COLITIS;

EID: 39149138472     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-989410     Document Type: Review

References (167)

1. Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998; 16: 351-355
2. Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004; 18: 463-479
3. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Diagnostik und Therapie der Colitis ulcerosa. http://www.uni-duesseldorf.de/AWMF/ll/021-009.htm
4. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-697
5. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Diagnostik und Therapie des Morbus Crohn. Zeitschrift für Gastroenterologie 2003, 41: 19-68; http://www.uni-duesseldorf.de/awmf/ ll-na/021-004.htm
6. McLeod RS. Surgery for inflammatory bowel diseases. Dig Dis 2003; 21: 168-179
7. Schröder O, Sohn C, Stein J. Gastrointestinal and hepatobiliary complications during pregnancy. Geburtsh Frauenheilk 2000; 60: 333-344
8. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, Rutgeerts P. Familial aggregation in Crohn's disease. Increased age, adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111: 597-603
9. Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynecol Obstet 2004; 270: 79-85
10. Alstead EM, Nelson-Piercy C. Inflammatory bowel disease in pregnancy. Gut 2003; 52: 159-161
11. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980; 21: 469-474
12. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990; 99: 987-994
13. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997; 58: 229-237
14. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984; 6: 211-216
15. Bradley RJ, Rosen MP. Subfertility and gastrointestinal disease: "unexplained" is often undiagnosed. Obstet Gynecol Surv 2004; 59: 108-117
16. Ording Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease and after surgery compared to a population sample. Gastroenterology 2002; 122: 15-19
17. Johnson P, Richard C, Ravid A, Spencer L, Pinto E, Hanna M, Cohen Z, McLeod R. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004; 47: 1119-1126
18. Oresland T, Palmblad S, Ellstrom M, Berndtsson I, Crona N, Hulten L. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis 1994; 9: 77-81
19. Asztély M, Palmblad S, Wikland M, Hultén L. Radiological study of changes in the pelvis in women following proctocolectomy. Int J Colorectal Dis 1991; 6: 103-107
20. Mortier PE, Gambiez L, Karoui M, Cortot A, Paris JC, Quandalle P, Colombel JF. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol 2006; 30: 594-597
21. Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW, Paraskevas P, Clark SK, Tekkis PP. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007; 50: 1128-1138
22. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 591-599
23. Fielding JF, Cooke WT. Pregnancy and Crohn's disease. Br Med J 1970; 2: 76-77
24. Moody G, Probert CS, Srivastava EM, Rhodes J, Mayberry JF. Sexual dysfunction amongst women with Crohn's disease: a hidden problem. Digestion 1992; 52: 179-183
25. Hueting WE, Gooszen HG, van Laarhoven CJ. Sexual function and continence after ileo pouch anal anastomosis: a comparison between a meta-analysis and a questionnaire survey. Int J Colorectal Dis 2004; 19: 215-218
26. Bambrick M, Fazio VW, Hull TL, Pucel G. Sexual function following restorative proctocolectomy in women. Dis Colon Rectum 1996; 39: 610-614
27. Berndtsson I, Oresland T, Hulten L. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study. Scand J Gastroenterol 2004; 39: 374-379
28. Damgaard B, Wettergren A, Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis. Dis Colon Rectum 1995; 38: 286-289
29. Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 735-742
30. Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984; 19: 724-732
31. Miller JP. Inflammatory bowel disease in pregnancy. A review. J Royal Soc Med 1986; 79: 221-229
32. Nwokolo CU, Tan WC, Andrews HA, Allan RN. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut 1994; 35: 220-223
33. Castiglione F, Pignata S, Morace F, Sarubbi A, Baratta MA, D'Agostino L, D'Arienzo A, Mazzacca G. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996; 28: 199-204
34. Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ, European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55: i36-i58
35. Buyon JP. The effects of pregnancy on autoimmune diseases. J Leukoc Biol 1998; 63: 281-287
36. Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrugger R, Langholz E, Munkholm P, European Collaborative study group on Inflammatory Bowel Disease. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006; 101: 1539-1545
37. Kitayama T, Funayama Y, Fukushima K, Shibata C, Takahashi K, Ogawa H, Ueno T, Hashimoto A, Sasaki I. Anal function during pregnancy and postpartum after ileal pouch anal anastomosis for ulcerative colitis. Surg Today 2005; 35: 211-215
38. Lamah M, Scott HJ. Inflammatory bowel disease and pregnancy. Int J Colorectal Dis 2002; 17: 216-222
39. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: A controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989; 160: 998-1001
40. Zeldis JB. Pregnancy and inflammatory bowel disease. West J Med 1989; 151: 168-171
41. Anderson JB, Turner GM, Williamson RC. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med 1987; 80: 492-494
42. Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006; 55: 1198-1206
43. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998; 27: 213-224
44. Lang E, Schäfer W, Steegmüller KW, Höckel M, Junginger T. Die Perforation bei Morbus Crohn als Komplikation in der Schwangerschaft. Geburtsh Frauenheilk 1991; 51: 241-243
45. Roether M, Reichardt HD, Oechsner MG. Erstmanifestation eines Morbus Crohn in der Spätschwangerschaft: Indikation zur Ileozäkalresektion mit nachfolgendem Spontanpartus. Geburtsh Frauenheilk 2005; 65: 974-977
46. Subhani JM, Hamiliton MI. Review article: The management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 1998; 12: 1039-1053
47. Hanan IM, Kirsner JB. Inflammatory bowel disease in the pregnant woman. Clin Perinatal 1985; 12: 669-682
48. Schade RR, Thiel DHV, Gavaler JS. Chronic idiopathic ulcerative colitis. Pregnancy and fetal outcome. Dig Dis Sci 1984; 29: 614-619
49. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - A population-based cohort study. Am J Obstet Gynecol 1997; 177: 942-946
50. Fonager K, Sørensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: A follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93: 2426-2430
51. Norgard B, Fonager K, Sørensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: A nationwide Danish cohort study. Am J Gastroenterol 2000; 95: 3165-3170
52. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol 2000; 95: 1021-1026
53. Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M, the Study Group for Inflammatory Bowel Diseases GSMII. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol 2007; 22: 542-549
54. Rogers RG, Katz VL. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: A retrospective review. Am J Perinatol 1995; 12: 262-264
55. Cornish JA, Tan EK, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP. A Meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007; 56: 830-837
56. Dominitz JA, Young JCC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: A population-based cohort study. Am J Gastroenterol 2002; 97: 641-648
57. Nørgård B, Puho E, Pedersen L, Czeizel AE, Sørensen HT. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol 2003; 98: 2006-2010
58. Teahon K, Pearson M, Levi AJ, Bjarnason I. Elemental diet in the management of Crohn's disease during pregnancy. Gut 1991; 32: 1079-1081
59. Tresadern JC, Falconer GF, Turnberg LA, Irving MH. Successful completed pregnancy in a patient maintained on home parenteral nutrition. BMJ 1983; 286: 602-603
60. Czeizel AE, Toth M, Rockenbauer M. Population-based case-control study of folic acid supplementation during pregnancy. Teratology 1996; 53: 345-351
61. Reddy SI, Wolf JL. Management issues in women with inflammatory bowel disease. J Am Osteopath Assoc 2001; 101 (12 Suppl Pt 2): S17-23
62. Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod (Paris) 2005; 34: 581-588
63. Ilnyckyji A, Blanchard JF, Rawsthorne P, Bernstein CN. Perianal Crohn's disease and pregnancy: Role of the mode of delivery. Am J Gastroenterol 1999; 94: 3274-3278
64. Brandt LJ, Estabrook SG, Reinus JF. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease. Am J Gastroenterol 1995; 90: 1918-1922
65. Remzi FH, Gorgun E, Bast J, Schroeder T, Hammel J, Philipson E, Hull TL, Church JM, Fazio VW. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005; 48: 1691-1699
66. Hahnloser D, Pemberton JH, Wolff BG, Larson D, Harrington J, Farouk R, Dozois RR. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum 2004; 47: 1127-1135
67. Katz JA, Pore G. Inflammatory bowel disease and pregnancy. Inflamm Bowel Dis 2001; 7: 146-157
68. Donaldson RM. Management of medical problems in pregnancy - inflammatory bowel disease. N Engl J Med 1985; 312: 1616-1619
69. Warrell DW, Taylor R. Outcome for the foetus of mothers receiving prednisolone during pregnancy. Lancet 1968; 1: 117-118
70. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 1984; 25: 52-56
71. Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: A case-controlled retrospective analysis. Br J Obstet Gynecol 1986; 93: 1124-1131
72. Wolfson K, Cohen Z, McLeod RS. Crohn's disease and pregnancy. Dis Colon Rectum 1990; 33: 869-873
73. Travis S. Advances in therapeutic approaches to ulcerative colitis and Crohn's disease. Curr Gastroenterol Rep 2005; 7: 475-484
74. Stein RB, Hanauer SB. Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf 2000; 23: 429-448
75. Craxi A, Pagliarello F. Possible embryotoxicity of sulfasalazine. Arch Intern Med 1980; 140: 1674
76. Newman NM, Coney JF. Possible teratogenicity of sulphasalazine. Med J Aust 1983; 1: 528-529
77. Hoo JJ, Hadro TA, Von Behren P. Possible teratogenicity of sulfasalazine. N Engl J Med 1988; 318: 1128
78. Norgard B, Czeizel AE, Rockenbauer M, Olsen J, Sørensen HT. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001; 15: 483-486
79. Czeizel EA, Dudas I. Prevention of the first occurrence of neuraltube defects with folic acid supplementation. N Engl J Med 1992; 327: 1832-1835
80. Esbjörner E, Järnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand 1987; 76: 137-142
81. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981; 80: 72-76
82. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, Koren G. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998; 114: 23-28
83. Marteau P, Tennenbaum R, Elefant E, Lémann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 1998; 12: 1101-1108
84. Schroeder KW. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Scand J Gastroenterol Suppl 2002; 236: 42-44
85. Bell CM, Habal FM. Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol 1997; 92: 2201-2202
86. Marteau P, Crand J, Devaux CB. Mesalazine in pregnancy: fetal outcome in 76 IBD patients treated with Pentasa. Gastroenterology 1995; 108: A871
87. Habal FM, Hui G, Greenberg GR. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 1993; 105: 1057-1060
88. http://www.fda.gov/cder/foi/label/2000/20610lbl.pdf
89. Hanauer SB. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis. Aliment Pharmacol Ther 2006; 24: 37-40
90. Bressler B, Sands BE. Review article: Medical therapy for fistulizing Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1283-1293
91. Roe FJ. Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery 1983; 93: 158-164
92. Greenberg F. Possible metronidazole teratogenicity and clefting. Am J Med Genet 1985; 22: 825
93. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172: 525-529
94. Caro-Paton T, Carvajal A, Diego IM, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997; 44: 179-183
95. Heisterberg L, Branebjerg PE. Blood and milk concentrations of metronidazole in mothers and infants. J Perinat Med 1983; 11: 114-120
96. Passmore CM, McElnay JC, Rainey EA, D'Arcy PF. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988; 26: 45-51
97. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, Schick B, Bonati M, Moretti M, Lalkin A, Pastuszak A, Koren G. Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study. Antimicrob Agents Chemother 1998; 42: 1336-1339
98. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003; 20: 405-414
99. Linseman DA, Hampton LA, Branstetter DG. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol 1995; 28: 59-64
100. Berkovitch M, Pastuszak A, Garzarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994; 84: 535-538
101. Harmon T, Burkhart G, Applebaum H. Perforated pseudomembranous colitis in the breast-fed infant. J Pediatr Surg 1992; 27: 744-746
102. Gardner DK, Gabbe SG, Harter C. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant. Clin Pharm 1992; 11: 352-354
103. Briggs GG, Freeman FR, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia, PA: Lippincott, Williams and Wilkins, 2005
104. Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006; 107: 1120-1138
105. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990; 99: 443-446
106. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003; 124: 9-17
107. Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum Clin NA 1997; 23: 149-167
108. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease. Ann Intern Med 1989; 111: 641-649
109. Nørgård B, Pedersen L, Christensen LA, Sørensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007; 102: 1406-1413
110. Mottet C, Juillerat P, Gonvers JJ, Froehlich F, Burnand B, Vader JP, Michetti P, Felley C. Pregnancy and Crohn's disease. Digestion 2005; 71: 54-61
111. Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 1994; 49: 79-81
112. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 5th ed. Baltimore: Williams & Wilkins, 1998: 702-705
113. Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA. The effects of methotrexate on pregnancy, fertility and lactation. QJM 1999; 92: 551-563
114. Connell WR. Safety of drug therapy for inflammatory bowel disease in pregnant and nursing women. Inflamm Bowel Dis 1996; 2: 33-47
115. Kane S. Managing pregnancy in IBD. Inflamm Bowel Dis Monitor 2002; 4: 2-11
116. Johns DG, Rutherford LD, Leighton PC, Vogel CL. Secretion of methotrexate into human milk. Am J Obstet Gynecol 1972; 112: 978-980
117. American Academy of Pediatrics, Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776-779
118. Lichtiger A, Present D, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-1845
119. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporine in ulcerative colitis: a five year experience. Am J Gastrorenterol 1999; 94: 1587-1592
120. Nguyen GC, Harris ML, Dassopoulos T. Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease. Curr Gastroenterol Rep 2006; 8: 499-505
121. Armenti VT, Moritz MJ, Davison JM. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998; 19: 219-232
122. Bertschinger P, Himmelmann A, Risti B, Follath F. Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol 1995; 90: 330
123. Marion JF, Rubin PH, Lichtiger S et al. Cyclosporine is safe for severe colitis complicating pregnancy. Am J Gastroenterol 1996; 91: 1975
124. Flechner SM, Katz AR, Rogers AJ, van Buren C, Kahan BD. The presence of cyclosporin in body tissues and fluids during pregnancy. Am J Kidney Dis 1985; 5: 60-63
125. Munoz-Flores-Thiagarajan KD, Easterling T, Davis C, Bond EF. Breastfeeding by a cyclosporine-treated mother. Obstet Gynecol 2001; 97: 816-818
126. Thiru Y, Bateman DN, Coulthard MG. Successful breast feeding while mother was taking cyclosporin. BMJ 1997; 315: 463
127. Gonzalez-Lama Y, Gisbert JP, Mate J. The role of tacrolimus in inflammatory bowel disease: a systematic review. Dig Dis Sci 2006; 51: 1833-1840
128. Ng SC, Arebi N, Kamm MA. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 129-134
129. Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000; 70: 1718-1721
130. Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, Warty V, Starzl TE. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997; 64: 559-565
131. French AE, Soldin SJ, Soldin OP, Koren G. Milk transfer and neonatal safety of tacrolimus. Ann Pharmacother 2003; 37: 815-818
132. Gardiner SJ, Begg EJ. Breastfeeding during tacrolimus therapy. Obstet Gynecol 2006; 107: 453-455
133. Korelitz BI. Pregnancy, fertility, and inflammatory bowel disease. Am J Gastroenterol 1985; 80: 365-370
134. Modigliani R. Drug therapy for ulcerative colitis during pregnancy. Eur J Gastroenterol Hepatol 1997; 9: 854-857
135. Bulmash JM. Systemic lupus erythematosus and pregnancy. Obstet Gynecol Ann 1978; 7: 153-194
136. Bulmash JM. Rheumatoid arthritis and pregnancy. Obstet Gynecol Ann 1979; 8: 223-276
137. Fitzsimons R, Greenberger PA, Patterson R. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol 1986; 78: 349-353
138. Pinsky L, DiGeorge AM. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science 1965; 147: 402-403
139. Fraser FC, Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology 1995; 51: 45-46
140. Rodriguez-Pinella E, Martinez-Frias ML. Corticosteroids during pregnancy and oral clefts: a case control study. Teratology 1998; 58: 2-5
141. Beitens IZ, Bayarrd F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972; 81: 936-945
142. Armenti VT, Moritz MJ, Cardonick EH, Davison JM. Immunosuppression in pregnancy: choices for infant and maternal health. Drugs 2002; 62: 2361-2375
143. Burakoff R, Opper F. Pregnancy and nursing. Gastroenterol Clin N Am 1995; 24: 689-698
144. Khanna D, McMahon M, Furst DE. Safety of tumor necrosis factor-alpha antagonists. Drug Saf 2004; 27: 307-324
145. Osterman MT, Lichtenstein GR. Current and future anti-TNF therapy for inflammatory bowel disease. Curr Treat Options Gastroenterol 2007; 10: 195-207
146. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657
147. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 2005; 54: 890
148. Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford) 2007; 46: 695-698
149. Lichtenstein G, Cohen RD, Feagan BG, Sandborn W, Salzberg B, Chen D, Diamond R. Safety of infliximab in Crohn's disease: data from the 5000-patient TREAT registry. Gastroenterology 2004; 126: A54
150. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385-2392
151. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005; 21: 733-738
152. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006; 4: 1255-1258
153. Shrim A, Koren G. Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy. Can Fam Physician 2005; 51: 667-668
154. Einarson A, Mastroiacovo P, Arnon J, Ornoy A, Addis A, Malm H, Koren G. Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol 2000; 14: 185-187
155. Hagemann TM. Gastrointestinal medications and breastfeeding. J Hum Lact 1998; 14: 259-262
156. Levi AJ, Fisher AM, Hughes L, Hendry WF. Male infertility due to sulphasalazine. Lancet 1979; 2: 276-278
157. Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril 1979; 31: 538-540
158. Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut 1981; 22: 452-455
159. Shaffer JL, Kershaw A, Berrisford MH. Sulphasalazine-induced infertility reversed on transfer to 5-aminosalicylic acid. Lancet 1984; 1: 1240
160. Zelissen PM, van Hattum J, Poen H, Scholten P, Gerritse R, te Velde ER. Influence of salazosulfapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroenterol 1988; 23: 1100-1104
161. Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 395-399
162. Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000; 95: 684-688
163. Kane SV. What's good for the goose should be good for the gander - 6-MP use in fathers with inflammatory bowel disease. Am J Gastroenterol 2000; 95: 581-582
164. Burnell D, Mayberry J, Calcraft BJ, Morris JS, Rhodes J. Male fertility in Crohn's disease. Postgrad Med J 1986; 62: 269-272
165. Narendranathan M, Sandler RS, Suchindran CM, Savitz DA. Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989; 11: 403-406
166. Farthing MJ, Dawson AM. Impaired semen quality in Crohn's disease - drugs, ill health, or undernutrition? Scand J Gastroenterol 1983; 18: 57-60
167. El-Tawil AM. Zinc deficiency in men with Crohn's disease may contribute to poor sperm function and male infertility. Andrologia 2003; 35: 337-341